Insider Ownership

Name	Relationship / Title	Current Shares	Trading Activity
adelman robert j	Director	2,125,493	View
Date	Type	Shares Traded	Price Range USD
11/13/2007	Acquisition (Non Open Market)	1,825,493	n/a
11/13/2007	Buy	300,000	10.00
barker jason	Officer	10,000	View
Date	Type	Shares Traded	Price Range USD
11/07/2007	Statement of Ownership	0	n/a
druzgala pascal	Officer	205,288	View
Date	Type	Shares Traded	Price Range USD
11/13/2007	Acquisition (Non Open Market)	1,122	n/a
11/07/2007	Statement of Ownership	0	n/a
11/07/2007	Statement of Ownership	0	n/a
evnin luke	Beneficial Owner (10% or more)	3,576,862	View
Date	Type	Shares Traded	Price Range USD
11/13/2007	Buy	300,000	10.00
11/13/2007	Acquisition (Non Open Market)	3,276,862	n/a
goddard paul	Officer	57,187	View
Date	Type	Shares Traded	Price Range USD
11/13/2007	Acquisition (Non Open Market)	3,021	n/a
11/07/2007	Statement of Ownership	0	n/a
11/07/2007	Statement of Ownership	0	n/a
milner peter g	Officer	31,903	View
Date	Type	Shares Traded	Price Range USD
11/13/2007	Acquisition (Non Open Market)	35,955	n/a
11/13/2007	Acquisition (Non Open Market)	11,784	n/a
11/07/2007	Statement of Ownership	0	n/a
11/07/2007	Statement of Ownership	0	n/a
mpm bioventures iii qp lp	Beneficial Owner (10% or more)	3,576,862	View
Date	Type	Shares Traded	Price Range USD
11/13/2007	Buy	300,000	10.00
11/13/2007	Acquisition (Non Open Market)	3,276,862	n/a
nomura phase4 ventures ltd	Beneficial Owner (10% or more)	2,447,731	View
Date	Type	Shares Traded	Price Range USD
11/13/2007	Acquisition (Non Open Market)	2,447,731	n/a
orbimed advisors llc	Director	2,125,493	View
Date	Type	Shares Traded	Price Range USD
11/13/2007	Buy	300,000	10.00
11/13/2007	Acquisition (Non Open Market)	1,825,493	n/a
simon nicholas j iii	Director	3,576,862	View
Date	Type	Shares Traded	Price Range USD
11/13/2007	Buy	300,000	10.00
11/13/2007	Acquisition (Non Open Market)	3,276,862	n/a
11/13/2007	Acquisition (Non Open Market)	4,402	n/a

Stock transaction information provided by EDGAR Online. ARYx Therapeutics makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.